CAS 212142-18-2: Vatalanib succinate
Description:Vatalanib succinate, with the CAS number 212142-18-2, is a small molecule that functions primarily as a tyrosine kinase inhibitor. It is designed to target specific receptors involved in angiogenesis, particularly the vascular endothelial growth factor (VEGF) receptors, which play a crucial role in tumor growth and metastasis. This compound is characterized by its ability to inhibit tumor vascularization, thereby potentially limiting the growth of various cancers. Vatalanib succinate is typically administered in a pharmaceutical formulation, often as a salt to enhance its solubility and bioavailability. The substance exhibits a moderate to high affinity for its target receptors, which contributes to its therapeutic efficacy. Additionally, it is important to consider its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, which influence its overall effectiveness and safety profile in clinical settings. As with many targeted therapies, ongoing research continues to explore its potential applications and optimize its use in cancer treatment.
Formula:C20H15ClN4·C4H6O4
InChI:InChI=1S/C20H15ClN4.C4H6O4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14;5-3(6)1-2-4(7)8/h1-12H,13H2,(H,23,25);1-2H2,(H,5,6)(H,7,8)
InChI key:InChIKey=LLDWLPRYLVPDTG-UHFFFAOYSA-N
SMILES:O=C(O)CCC(=O)O.ClC1=CC=C(C=C1)NC2=NN=C(C=3C=CC=CC23)CC=4C=CN=CC4
- Synonyms:
- 1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-, butanedioate (1:1)
- Butanedioic acid, compd. with N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine (1:1)
- Cgp 79787D
- N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine butanedioate
- N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine butanedioate (1:1)
- Ptk 787
- Ptk 787/Zk 222584
- Ptk 787Zk22258
- Zk 222584

Butanedioic acid, compd. withN-(4-chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine (1:1)OTHER CA INDEX NAMES:1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-,butanedioate (1:1)
Ref: IN-DA00I42A
1g | To inquire | ||
5mg | 72.00 € | ||
10mg | 99.00 € | ||
25mg | 159.00 € | ||
50mg | 165.00 € | ||
100mg | 278.00 € | ||
250mg | 627.00 € |

Vatalanib Succinate
Ref: 3B-V0198
25mg | 236.00 € |

Vatalanib succinate
Ref: TM-T71897
25mg | 1,444.00 € | ||
50mg | 1,882.00 € | ||
100mg | 2,375.00 € |

Vatalanib succinate
Ref: 3D-MIA14218
100mg | 877.00 € | ||
250mg | 1,344.00 € |